Prosecution Insights
Last updated: April 19, 2026

Examiner: AGGARWAL, SAHIL CHANDER

Tech Center 1600 • Art Units: 1623

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
4
Total Applications
Interview Lift
1175
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
11.1%
§102 Novelty
44.4%
§103 Obviousness
22.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18511706 METHODS FOR MANAGING DISEASES IN CUT FLOWERS Non-Final OA Niacet Corporation
18388057 TOPICAL COMPOSITION CONTAINING CANNABINOIDS Non-Final OA TF Holdings LLC
18503371 METHODS OF TREATING EYE PAIN AND EYE DISORDERS Non-Final OA Aisa Pharma, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month